Amyloid fibril formation by pulmonary surfactant protein C

被引:94
|
作者
Gustafsson, M
Thyberg, J
Näslund, J
Eliasson, E
Johansson, J [1 ]
机构
[1] Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden
[2] Karolinska Inst, Med Nobel Inst, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden
[3] Karolinska Inst, Dept Clin Neurosci, S-14186 Huddinge, Sweden
[4] Karolinska Inst, Dept Environm Med, S-17177 Stockholm, Sweden
关键词
amyloid fibril; lipid-associated peptide; protein palmitoylation; pulmonary surfactant; surfactant protein C;
D O I
10.1016/S0014-5793(99)01692-0
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Lung surfactant protein C (SP-C) is a lipopeptide that contains two fatty acyl (palmitoyl) chains bound via intrinsically labile thioester bonds, SP-C can transform from a monomeric alpha-helix into beta-sheet aggregates, reminiscent of structural changes that are supposed to occur in amyloid fibril formation, SP-C is here shown to form amyloid upon incubation in solution. Furthermore, one patient with pulmonary alveolar proteinosis (PAP, a rare disease where lung surfactant proteins and lipids accumulate in the airspaces) and six healthy controls have been studied regarding presence and composition of amyloid fibrils in the cell-free fraction of bronchoalveolar lavage (BAL) fluid. Abundant amyloid fibrils were found in BAL fluid from the patient with PAP and, in low amounts, in three of the six healthy controls. SDS-insoluble fibrillar material associated with PAP mainly consists of SP-C, in contrast to the fibrils found in controls. Fibrillated SP-C has to a significant extent lost the palmitoyl groups, and removal of the palmitoyl groups in vitro increases the rate of fibril formation, (C) 1999 Federation of European Biochemical Societies.
引用
收藏
页码:138 / 142
页数:5
相关论文
共 50 条
  • [41] Aggregation and amyloid fibril formation of the prion protein is accelerated in the presence of glycogen
    Panza, Giannantonio
    Stoehr, Jan
    Birkmann, Eva
    Riesner, Detlev
    Willbold, Dieter
    Baba, Otto
    Terashima, Tatsuo
    Dumpitak, Christian
    [J]. REJUVENATION RESEARCH, 2008, 11 (02) : 365 - 369
  • [42] The role of protein stability, solubility, and net charge in amyloid fibril formation
    Schmittschmitt, JP
    Scholtz, JM
    [J]. PROTEIN SCIENCE, 2003, 12 (10) : 2374 - 2378
  • [43] Effect of Mutations on Apolioprotein C-II amyloid fibril formation
    Mao, Yu
    Griffin, Mike
    Mok, Yee-Foong
    Teoh, Chai-Lean
    Gooley, Paul
    Howlett, Geoff
    [J]. PROTEIN SCIENCE, 2012, 21 : 88 - 88
  • [44] The role of lipid-protein interactions in amyloid-type protein fibril formation
    Gorbenko, Galyna P.
    Kinnunen, Pam K. J.
    [J]. CHEMISTRY AND PHYSICS OF LIPIDS, 2006, 141 (1-2) : 72 - 82
  • [45] On the lag phase in amyloid fibril formation
    Arosio, Paolo
    Knowles, Tuomas P. J.
    Linse, Sara
    [J]. PHYSICAL CHEMISTRY CHEMICAL PHYSICS, 2015, 17 (12) : 7606 - 7618
  • [46] Apolipoproteins and amyloid fibril formation in atherosclerosis
    Chai Lean Teoh
    Michael D.W.Griffin
    Geoffrey J.Howlett
    [J]. Protein & Cell, 2011, 2 (02) : 116 - 127
  • [47] Mechanisms of amyloid fibril formation by proteins
    Kumar, Santosh
    Udgaonkar, Jayant B.
    [J]. CURRENT SCIENCE, 2010, 98 (05): : 639 - 656
  • [48] Amyloid fibril formation is suppressed in microgravity
    Matsushita, Hiroaki
    Isoguchi, Aito
    Okada, Masamitsu
    Masuda, Teruaki
    Misumi, Yohei
    Ichiki, Yuko
    Ueda, Mitsuharu
    Ando, Yukio
    [J]. BIOCHEMISTRY AND BIOPHYSICS REPORTS, 2021, 25
  • [49] Effect of Surfaces on Amyloid Fibril Formation
    Moores, Bradley
    Drolle, Elizabeth
    Attwood, Simon J.
    Simons, Janet
    Leonenko, Zoya
    [J]. PLOS ONE, 2011, 6 (10):
  • [50] Elucidating the kinetics of β-amyloid fibril formation
    Edwin, NJ
    Bantchev, GB
    Russo, PS
    Hammer, RP
    McCarley, RL
    [J]. NEW POLYMERIC MATERIALS, 2005, 916 : 106 - 118